Featured: Impact of Tumor Size on the Survival Benefit of Anatomic Versus Non-Anatomic Resection for #IntrahepaticCholangiocarcinoma . @Jun_Kawashima_x @Mujtabakhalil @timpawlik. . @vitor__moutinho.@SyedAAhmad5

#AudioVisualAbstract : Improving Recurrence Prediction in #IntrahepaticCholangiocarcinoma : The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post- #Hepatectomy Outcomes @Jun_Kawashima_x @timpawlik. @NabeelZafarMD.@SyedAAhmad5

Spatial immunophenotypes predict clinical outcome in #intrahepaticcholangiocarcinoma. 🔓#OpenAccess at👉 #LiverTwitter

FREELY AVAILABLE: The Landmark Series: #IntrahepaticCholangiocarcinoma @McMastersKelly @SocSurgOnc

🆕Hepatology Snapshot❕. Surgical treatment of #IntrahepaticCholangiocarcinoma. By @sapisochin & colleagues . 🆓at👉 #iCCA.#LiverTransplantation.#LiverTwitter

Circular RNA (circACTN4) could be a prognostic biomarker & therapeutic target for #ICC . ➡️circACTN4.✅highly expressed in #intrahepaticcholangiocarcinoma.✅positively associated with #tumorgrowth & #metastasis. 🔓#OpenAcces at👉 #LiverTwitter

Interactive #Tumorboard #MDT discussion on #intrahepaticcholangiocarcinoma #iCCA at #ILC2022 chaired by @DrAngelaLamarca with @Alexfornergon #JulienEdeline #MariaHawkins @EASLnews @EASLedu

🆕#CPG in press❕. EASL-ILCA Clinical Practice Guidelines on the management of #IntrahepaticCholangiocarcinoma. 🆓Find it here👉 @EASLedu.@EASLnews.#iCCA.#LiverTwitter

JULY ISSUE: #TumorNecrosis Impacts Prognosis of Patients Undergoing Resection for T1 #IntrahepaticCholangiocarcinoma. @McMastersKelly @SocSurgOnc

DECEMBER ISSUE: A Novel Classification of #IntrahepaticCholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis. @McMastersKelly @SocSurgOnc

#GeographicDisparities in #ReferralRates and #OncologicOutcomes of #IntrahepaticCholangiocarcinoma : A Population-Based Study. @drymtn #VisualAbstract @McMastersKelly

#TumorBurden Dictates Prognosis Among Patients Undergoing Resection of #IntrahepaticCholangiocarcinoma : A Tool to Guide Post-Resection #AdjuvantChemotherapy? @DTsilimigras @timpawlik #VisualAbstract @McMastersKelly

AUGUST ISSUE: The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with #IntrahepaticCholangiocarcinoma. #hepatobiliarytumors @McMastersKelly @SocSurgOnc

JUNE ISSUE: Laparoscopic Approach to #IntrahepaticCholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging. @McMastersKelly @SocSurgOnc

May Issue: Benchmarks in #LiverResection for #IntrahepaticCholangiocarcinoma .@timpawlik @OhioStateSurg @ARuzzenente @skmaithel @EmorySurgery @ChamoGui @uOttawaMed @BasGrootKoerkamp @ItaruEndo. @HalletJulie

✅#caseoftheday solved! Full description👇🏼.#FOAMRad #RadEd #ultrasound @icus_society #contrastenhancedultrasound #echofirst #SonoVue #Samsunghme #samsunghealthcare #intrahepaticcholangiocarcinoma #diagnosticimaging

Today, TriSalus announced the first patient enrolled in its second Pressure-Enabled Regional Immuno-Oncology (PERIO™-02) #clinicaltrial evaluating SD-101 in adults with #hepatocellularcarcinoma or #intrahepaticcholangiocarcinoma. Learn more: #LiverTwitter

SEPTEMBER ISSUE: Therapeutic Index Associated with #Lymphadenectomy Among Patients with #IntrahepaticCholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? @McMastersKelly @SocSurgOnc

SEPTEMBER ISSUE: #HepaticArterialInfusionPump Chemotherapy for Unresectable #IntrahepaticCholangiocarcinoma: A Systematic Review and Meta-Analysis.@McMastersKelly @SocSurgOnc

Honored to Contribute to the Comprehensive Review on Intrahepatic Cholangiocarcinoma - @supriyadocc .@AnjanaPillaiMD | @rachnatshroff . #Cancer #IntrahepaticCholangiocarcinoma #OncoDaily #Oncology #Medicine #Health #MedEd #MedX.